PBRM1 presents a potential ctDNA marker to monitor response to neoadjuvant chemotherapy in cervical cancer. Li W, Huang Y, Xiao M, Zhao J, et al. iScience 2024;27:109160.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li W, Huang Y, Xiao M, Zhao J, et al. PBRM1 presents a potential ctDNA marker to monitor response to neoadjuvant chemotherapy in cervical cancer. iScience 2024;27:109160.
PMID: 38414861